Reliance Industries Ltd (RIL) said it has agreed to sell its entire 70% stake Gujarat’s Cambay Basin block to Dilip Shanghvi-promoted Sun Petrochemicals Pvt. Ltd (Sun Oil and Natural Gas) for an undisclosed amount...
TPG Capital to buy into Sai Life Sciences
TPG Capital said on Wednesday it will acquire a significant minority stake in Hyderabad-based Sai Life SciencesNSE -0.83 %, in what could be seen as renewed interest in India’s pharma and life-sciences space from large...
GlaxoSmithKline considers splitting up the group: FT
GlaxoSmithKline Plc (GSK.L) is considering a break-up of the group after investors pressed the company’s board to spin off its consumer division, the Financial Times reported on Friday. GSK Chairman Philip Hampton has...
Cipla plans acquisitions to enter new therapies, boost Africa business
Cipla is taking the acquisition and product in-licensing route to consolidate its business in Africa, the company’s second-largest market after India. Africa contributed 22 per cent to Cipla’s consolidated revenue in...
Aurobindo acquires Apotex Inc’s business in 5 European countries for €74 mn
Aurobindo Pharma Limited announced on Saturday that its step-down subsidiary, Agile Pharma B V (Netherlands), signed a definitive agreement to acquire Canadian pharmaceuticals company Apotex International Inc’s...
Cipla acquires 100% stake in South African pharmaceutical company Mirren
Cipla has acquired a 100 per cent stake in Mirren, a South African over-the-counter (OTC) pharmaceutical manufacturer and distributor. The transaction is subject to the approval by the Competition Commission of South...
Japan’s Takeda gains U.S. approval for $62 billion Shire buy
Takeda Pharmaceutical Co Ltd on Tuesday said it has received U.S. approval for its $62 billion acquisition of London-listed Shire Plc, taking the Japanese firm one step closer to its goal of becoming a global top 10...
3 PE firms in talks to buy stake in Glenmark API business
Three private equity (PE) funds are in early talks to acquire a significant stake in Glenmark Pharmaceuticals Ltd’s active pharmaceutical ingredient (API) business, said two people directly aware of the development...
Novartis hands investors Alcon spin-off, $5 billion share buyback
Novartis plans to spin off its Alcon eye care business to shareholders and buy back up to $5 billion in stock as Chief Executive Vas Narasimhan refocuses the Swiss group on prescription drugs. Shares in Novartis were up...
Lupin, Japan’s Nichi-Iko tie up to distribute biosimilar drug
Lupin Ltd, India’s third-largest drug maker, on Monday said it has tied up with Japan’s Nichi-Iko for the distribution, promotion and sale of Lupin’s recently filed biosimilar Etanercept in Japan. Etanercept is used for...
Takeda shareholder group aims to block $62 billion Shire deal
A group of Takeda Pharmaceutical Co Ltd shareholders is trying to build support to block the $62 billion acquisition of London-listed Shire Plc at an extraordinary general meeting, a leading member of the group told...
Icahn buys small stake in drugmaker Allergan: sources
Billionaire investor Carl Icahn has acquired a small stake in Allergan Plc (AGN.N) at a time when the drugmaker is under pressure from other activist shareholders, people familiar with the matter said on Wednesday...
